Fesarius Therapeutics, Inc. Announces FDA 510(K) Clearance for Dermisphere Hydrogel Dermal Regeneration Template

Fesarius Therapeutics, Inc. announceed that the US FDA has granted 510(k) clearance for its DermiSphere hydrogel Dermal Regeneration Template. This technology represents a new class of collagen-based dermal matrices designed for tissue integration and revascularization for improved wound healing and reduction of time to healing.